Skip to search formSkip to main contentSkip to account menu

vincristine liposome

Known as: Vincacine, Vincristine Liposomal, Liposomal Vincristine 
A liposomal formulation of Vincristine designed to reduce toxicity and improve efficacy. Vincristine binds irreversibly to microtubules and spindle… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
We report a case of a 76-year-old male with a history of relapsed and refractory diffuse large B-cell lymphoma (DLBCL).Our… 
2014
2014
AbstractPurposeVincristine sulfate (VCR) is a potent and widely used anti-tumor drug. Encapsulating VCR with liposomes improves… 
2013
2013
Purpose: We used two ligand-modified liposomal drugs to selectively deliver two different chemotherapeutics to tumor cells (TC… 
2011
2011
OBJECTIVE To prepare vincristine sulphate loaded poly (butylcyanoacrylate) nanoparticles (VCR-PBCA-NPs) and to investigate the in… 
2009
2009
This study was intended to assess the therapeutic effect and toxicity of Compound vincristine liposome on breast cancer in nude… 
2006
2006
To quantitatively evaluate the extravasation, accumulation and selectivity to tumor tissues of liposomal vincristine (LV), dorsal… 
Review
2004
Review
2004
INEX Pharmaceuticals is developing a liposomal formulation of vincristine [Onco TCS, vincacine, VSLI, Vincristine sulfate… 
2001
2001
Chemotherapeutic agents for cancer treatment typically are given as combination therapies from multiple classes of drugs (1–4…